HopeStage
Back to all studies
CompletedNCT00218270

Tobacco-free snuff to help reduce smokeless tobacco use

About this titleRead the official source — NCT00218270
Medication studyAges 18–70United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 70 years.

Listed locations
MinneapolisSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateDecember 2002
Recruitment status
Completed
Enrollment listed in the registry
138
Sponsor
National Institute on Drug Abuse (NIDA)
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 70 Years
Official registry ID
NCT00218270
Official title
Show the full official title

Treatment of Smokeless Tobacco Users

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Minneapolis

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute on Drug Abuse (NIDA), a research institute.

Did this study involve medication?

Yes. The study involved medication, including Tobacco free snuff.

Who was this study for?

Listed age limits: 18 years to 70 years.

Want to explore more studies?

Explore studies